Indocyanine Green Molecular Fluorescence Imaging Technique Using in Diagnosis and Treatment of Primary Liver Cancer
Status:
Recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
The of this study is to explore the clinical outcomes of indocyanine green molecular
fluorescence imaging in local resection of primary hepatocellular carcinoma (CNLC Ⅰa stage).